Curium’s Pulmotech MAA Receives the US FDA’s Approval for Lung Imaging

 Curium’s Pulmotech MAA Receives the US FDA’s Approval for Lung Imaging

Shots:

  • Pulmotech MAA is a single-photon emission agent targeted for lung imaging as an adjunct in the evaluation of pulmonary perfusion, further aiding the evaluation of peritoneovenous shunt patency in adults
  • The company offers to purchase vials in either a pack of 5 or in a box of 30 and has also made a similar version of MAA (macroaggregated albumin) in EU with expected commercialization in Apr 2020 in the US
  • Technetium Tc 99m Albumin Aggregated Injection is a radioactive diagnostic agent which is targeted for Lung scintigraphy and Scintigraphy of peritoneovenous shunt in adults

Click here ­to­ read full press release/ article | Ref: Curium | Image: behnace

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post